Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson’s Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators-Reference-Cited by-同舟云学术

Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson’s Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators

Published:2016-02-02 Issue:3 Volume:50 Page:733-740
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Yasue Ichiro¹²,Matsunaga Shinji¹,Kishi Taro¹,Fujita Kiyoshi²³,Iwata Nakao¹

Affiliation:

1. Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

2. Department of Psychiatry, Okehazama Hospital, Toyoake, Aichi, Japan

3. The Neuroscience Research Center, Toyoake, Aichi, Japan

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference30 articles.

1. A review of Parkinson’s disease;Davie;Br Med Bull,2008

2. Epidemiology of Parkinson’s disease;de Lau;Lancet Neurol,2006

3. Incidence of Parkinson’s disease: Variation by age, gender, and race/ethnicity;Van Den Eeden;Am J Epidemiol,2003

4. The prevalence of Parkinson’s disease: A systematic review and meta-analysis;Pringsheim;Mov Disord,2014

5. Atypical antipsychotics in Parkinson-sensitive populations;Friedman;J Geriatr PsychiatryNeurol,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism;Journal of Medicinal Chemistry;2024-07-31

2. Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem);Neurology, Neuropsychiatry, Psychosomatics;2024-06-22

3. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine;Journal of Integrative Neuroscience;2024-04-12

4. The pharmacological management of the behavioral aspects of Parkinson’s disease: an update;Expert Opinion on Pharmacotherapy;2023-07-26

5. Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature;Journal of Neuroscience and Neurological Disorders;2023-07-26